期刊文献+

MMP-9在中耳胆脂瘤中的表达和意义 被引量:2

The Expression and Significance of MMP-9 in Human Middle Ear Cholesteatoma
暂未订购
导出
摘要 目的研究基质金属蛋白酶-9(matrix metalloproteinase,MMP-9)在中耳胆脂瘤上皮中的表达,并探讨其与中耳胆脂瘤的血管形成以及胆脂瘤侵蚀行为的关系。方法采用免疫组织化学SP法检测MMP-9、Ⅳ型胶原蛋白在44例患者中耳胆脂瘤组织标本与10例正常外耳道组织中的表达。结果MMP-9在胆脂瘤上皮各层均有表达,在外耳道皮肤中为弱阳性表达;胆脂瘤基质周围微血管计数均数高于正常外耳道皮肤,二者差异具有统计学意义(P<0.05);MMP-9在胆脂瘤中的表达与周围微血管计数间呈正相关关系。结论MMP-9可能在中耳胆脂瘤血管生成中起重要作用。 Objective To analyze the expression of matrix metalloproteinase--9(MMP--9) in human middle ear cholesteatoma and to investigate the relationship between the angiogenesis induced by MMP--9 and the erosion behavior of middle ear cholesteatoma. Methods The expression of MMP--9 and collagen type IV were examined in 44 specimens with middle ear cholesteatoma and 10 specimens with normal ear canal skin by immunohistochemical S --P method. Results In cholesteatoma, MMP--9 protein was expressed in all the layers. There was a tendency of gradual increase from basal layer to corneous layers. For the normal ear canal skin , it was only expressed weekly. The mean number of vessals in normal ear canal skin was lower than that in cholesteatoma, and there was statistical significance between the two groups(P〈0.05). Conclusion MMP--9 is over--expressed in cholesteatoma and there is correlation between MMP--9 and microvesscl density(MVD). MMP--9 may play an important role in angiogenesis of human middle ear cholesteatoma.
出处 《听力学及言语疾病杂志》 CAS CSCD 2008年第5期412-414,共3页 Journal of Audiology and Speech Pathology
关键词 中耳胆脂瘤 基质金属蛋白酶-9 微血管密度 Middle ear cholesteatoma Matrix metalloproteinase(MMP--9) Microvessel density(MVD)
  • 相关文献

参考文献7

  • 1Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinase and metastasis[J]. Cancer Chemother Pharmacol 1999,43 42.
  • 2Schonermark M, Mester B, Kempf HG, et al. Expression of matrix metalloproteinases and their inhibitors in human cholesteatomas[J]. Acta Otolaryngol, 1996,116 : 451.
  • 3祝威,谢燕,王苹,张凤兰.两种基质金属蛋白酶在胆脂瘤和中耳癌中的表达[J].中华耳鼻咽喉科杂志,2001,36(2):119-122. 被引量:17
  • 4Eriko S. Stromal expression of matrix metalloproteinase-9 in middle ear cholesteatoma[J]. Am J Otol,2000,21:621.
  • 5Sudhof H, Dazert S,Gonzales A,et al. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma[J]. Am J Otol, 2000,21 : 793.
  • 6陈雄,孔维佳.血管内皮生长因子在中耳胆脂瘤中的表达及其临床意义[J].中华耳科学杂志,2004,2(2):129-132. 被引量:7
  • 7Riedel F,Gote K,Schwalb J,et al. Expression of 92-kDa type N collagenase correlates with angiogenic makers and poor survival in head and neck squamous cell earcinoma[J]. Int J Oncol, 2000,17 : 1 099.

二级参考文献24

  • 1[1]Sudhoff H, Bujia J, Fisseler-Eckhoff A, et al. Expression of the cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin. Laryngoscope 1995,105:1227 - 1231.
  • 2[2]Sudhoff H, Fisseler-Eckhoff A, Stark T, et al. Argyrophilic nucleolar organizer regions in auditory skin meatal and middle ear cholesteatoma. Clin Otolaryngol 1997,22:545 - 548.
  • 3[3]Schulz P, Bujia J, Holly A, et al. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha. Am J Otol 1993,14:82 - 87.
  • 4[4]Schilling V, Negri B, Bujia J, et al. Possible role of interleukin-1 alpha and interleukin-1 beta in the pathogenesis of cholesteatoma of middle ear. Am J Otol 1992,13:350 - 355.
  • 5[5]Marenda SA, Aufdemorte TB. Localization of cytokines in cholesteatoma tissue. Otolaryngol Head Neck Surg 1995,113:359 - 368.
  • 6[6]Sudhoff H, Bujia J, Holly A, et al. Functional characterization of middle ear mucosa residues in cholesteatoma samples. Am J Otol 1994,15:217 - 221.
  • 7[7]Folkman J, Klagsbrun M. Angiogenic factors. Science 1987,235:442 - 447.
  • 8[8]Dvorak HF. Tumors: wounds that do not heal. N Engl J Med 1986,315:1650- 1659.
  • 9[9]McKay IA, Leigh IM. Epidermal cytokines and their roles in cutaneous wound healing. Br J Dermatol 1991,124:513 - 518.
  • 10[10]Form DM, Pratt BM, Mardi JA. Endothelial cell proliferation during angiogenesis: in vitro modulation by basement membrane components. Lab Invest 1986,55:521 - 530.

共引文献21

同被引文献17

  • 1李楠,秦兆冰,董明敏.基质金属蛋白酶-9和肿瘤坏死因子-α在中耳胆脂瘤中的表达[J].临床耳鼻咽喉科杂志,2004,18(7):424-426. 被引量:6
  • 2孙文忠,徐志文,唐安洲.胆脂瘤上皮细胞增殖与凋亡的信息传导及基因调控[J].国外医学(耳鼻咽喉科学分册),2005,29(3):131-134. 被引量:2
  • 3徐志文,倪海峰.胆脂瘤型中耳炎骨质破坏机制及手术治疗[J].国外医学(耳鼻咽喉科学分册),2005,29(4):251-254. 被引量:11
  • 4Fang J, Shing Y, Wiederschain D, et al. Matrix metalloproteinase--2 is required for the switch to the angiogenic phenotype in a tumor model [J]. Proc Natl Acad Sci USA, 2002, 97 : 3 884.
  • 5Saleh HA, Mills RP. Classification and staging of cholesteatoma. Clin OtolaryngolAIlied Sci, 1999, 24: 355- 359.
  • 6Akimoto R, Pawankar R, Yagi T, et al. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-I, interleukin-1- alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec, 2000, 62: 257-265.
  • 7Hotokezaka H, Sakai E, Ohara N, et al. Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha Iipopolysaceharide, or peptidoglycan. J Cell Biochem, 2007, 101 : 122-134.
  • 8Shirazi MA, Muzaffar K, Leonetti JP, et al. Surgical treatment of pediatric cholesteatomas. Laryngoscope, 2006, 116: 1603-1607.
  • 9AlvesAL, Pereira CS, Ribeiro FdeA, et al. Analysis of histopathological aspects in acquired middle ear cholesteatoma. BrazJOtorhinolaryngol, 2008, 74: 835-841.
  • 10Dornelles Cde C, da Costa SS, Meurer L, et al. Comparison of acquired cholesteatoma between pediatric and adult patients. EurArch Otorhinolaryngol, 2009, 266: 1553-1561.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部